Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN--(BUSINESS WIRE)--The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global MRD testing market is projected to reach $6.67 billion by 2033...
Among 172 patients with untreated advanced solid tumors, all of them had actionable alterations, and 109 had druggable alterations.
Sanjay Goel, MD, MS, discusses the preliminary efficacy of tinengotinib monotherapy in advanced solid tumors according to data from a phase 1b/2 trial (NCT04742959).
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
CAR-T therapy is now seeing expansion for use in cancer treatment. Sino Biological produces a large range of promising target antigens for use in the cell therapy of solid tumors.